Apetrei Andreea, Molin Arnaud, Gruchy Nicolas, Godin Manon, Bracquemart Claire, Resbeut Antoine, Rey Gaëlle, Nadeau Gwenaël, Richard Nicolas
Normandy University, UNICAEN, Caen University Hospital, Department of Genetics, Reference Center of Rare Diseases of Calcium and Phosphorus Metabolism, EA 7450 BioTARGen, Caen, France.
Metropole Savoie Hospital Center, Genetics Department, Chambéry, France.
Bone Rep. 2021 Apr 23;14:101073. doi: 10.1016/j.bonr.2021.101073. eCollection 2021 Jun.
Pseudohypoparathyroidism type 1A (PHP1A) and pseudopseudohypoparathyroidism (PPHP) (Inactivating PTH/PTHrP Signaling Disorders type 2, IPPSD2) are two rare autosomal disorders caused by loss-of-function mutations on either maternal or paternal allele, respectively, in the imprinted gene, which encodes the α subunit of the ubiquitously-expressed stimulatory G protein (Gαs).
We investigated a synonymous variant NM_001077488.2: c.108C>A / p.(Val36=) identified in a family presenting with IPPSD2 phenotype. splicing prediction algorithms were in favor of a deleterious effect of this variant, by creating a new donor splicing site. The expression studies in blood suggested haploinsufficiency and showed an alternate splice product demonstrating the unmasking of a cryptic site, leading to a 34 base pairs deletion and the creation of a probable unstable RNA.We present the first familial case of IPPSD2 caused by a pathogenic synonymous variant in gene.
1A型假性甲状旁腺功能减退症(PHP1A)和假假性甲状旁腺功能减退症(PPHP)(2型失活性甲状旁腺激素/甲状旁腺激素相关蛋白信号传导障碍,IPPSD2)是两种罕见的常染色体疾病,分别由印记基因中母本或父本等位基因的功能丧失突变引起,该印记基因编码普遍表达的刺激性G蛋白(Gαs)的α亚基。
我们研究了在一个表现出IPPSD2表型的家族中鉴定出的同义变体NM_001077488.2:c.108C>A / p.(Val36=)。剪接预测算法认为该变体具有有害作用,因为它会产生一个新的供体剪接位点。血液中的表达研究表明存在单倍体不足,并显示出一种交替剪接产物,该产物证明了一个隐蔽位点的暴露,导致34个碱基对的缺失并产生了可能不稳定的RNA。我们报告了首例由该基因中的致病性同义变体引起的IPPSD2家族病例。